Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD
Ingelheim and Heidelberg (ots) - - Aims to identify of novel epigenetic drivers to find new approaches for treating COPD - Crowdsourcing used to find unconventional solutions and identify the best talent from around the world - New research team will be established at the BioMed X Innovation Center in Heidelberg, ...
mehr